Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation

Liang Zhao,1,* Rongjian Su,2,* Wenyu Cui,3 Yijie Shi,1 Liwei Liu,1 Chang Su4 1School of Pharmacy, Liaoning Medical University, Jinzhou, People's Republic of China; 2Central Laboratory of Liaoning Medical University, Jinzhou, People’s Republic of China; 3National Vaccine and Seru...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhao L, Su R, Cui W, Shi Y, Liu L, Su C
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/9114697ab4b548d284f2f0c7cd208140
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9114697ab4b548d284f2f0c7cd208140
record_format	dspace
spelling	oai:doaj.org-article:9114697ab4b548d284f2f0c7cd2081402021-12-02T00:37:57ZPreparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation1178-2013https://doaj.org/article/9114697ab4b548d284f2f0c7cd2081402014-05-01T00:00:00Zhttp://www.dovepress.com/preparation-of-biocompatible-heat-labile-enterotoxin-subunit-b-bovine--a16683https://doaj.org/toc/1178-2013 Liang Zhao,1,* Rongjian Su,2,* Wenyu Cui,3 Yijie Shi,1 Liwei Liu,1 Chang Su4 1School of Pharmacy, Liaoning Medical University, Jinzhou, People's Republic of China; 2Central Laboratory of Liaoning Medical University, Jinzhou, People’s Republic of China; 3National Vaccine and Serum Institute, Beijing, People’s Republic of China; 4School of Veterinary Medicine, Liaoning Medical University, Jinzhou, People’s Republic of China *These authors contributed equally to this work Abstract: Heat-labile enterotoxin subunit B (LTB) is a non-catalytic protein from a pentameric subunit of Escherichia coli. Based on its function of binding specifically to ganglioside GM1 on the surface of cells, a novel nanoparticle (NP) composed of a mixture of bovine serum albumin (BSA) and LTB was designed for targeted delivery of 5-fluorouracil to tumor cells. BSA-LTB NPs were characterized by determination of their particle size, polydispersity, morphology, drug encapsulation efficiency, and drug release behavior in vitro. The internalization of fluorescein isothiocyanate-labeled BSA-LTB NPs into cells was observed using fluorescent imaging. Results showed that BSA-LTB NPs presented a narrow size distribution with an average hydrodynamic diameter of approximately 254±19 nm and a mean zeta potential of approximately -19.95±0.94 mV. In addition, approximately 80.1% of drug was encapsulated in NPs and released in the biphasic pattern. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay showed that BSA-LTB NPs exhibited higher cytotoxic activity than non-targeted NPs (BSA NPs) in SMMC-7721 cells. Fluorescent imaging results proved that, compared with BSA NPs, BSA-LTB NPs could greatly enhance cellular uptake. Hence, the results indicate that BSA-LTB NPs could be a potential nanocarrier to improve targeted delivery of 5-fluorouracil to tumor cells via mediation of LTB. Keywords: heat-labile enterotoxin subunit B, nanoparticle, bovine serum albumin, 5-fluorouracilZhao LSu RCui WShi YLiu LSu CDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 2149-2156 (2014)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Zhao L Su R Cui W Shi Y Liu L Su C Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation
description	Liang Zhao,1,* Rongjian Su,2,* Wenyu Cui,3 Yijie Shi,1 Liwei Liu,1 Chang Su4 1School of Pharmacy, Liaoning Medical University, Jinzhou, People's Republic of China; 2Central Laboratory of Liaoning Medical University, Jinzhou, People’s Republic of China; 3National Vaccine and Serum Institute, Beijing, People’s Republic of China; 4School of Veterinary Medicine, Liaoning Medical University, Jinzhou, People’s Republic of China *These authors contributed equally to this work Abstract: Heat-labile enterotoxin subunit B (LTB) is a non-catalytic protein from a pentameric subunit of Escherichia coli. Based on its function of binding specifically to ganglioside GM1 on the surface of cells, a novel nanoparticle (NP) composed of a mixture of bovine serum albumin (BSA) and LTB was designed for targeted delivery of 5-fluorouracil to tumor cells. BSA-LTB NPs were characterized by determination of their particle size, polydispersity, morphology, drug encapsulation efficiency, and drug release behavior in vitro. The internalization of fluorescein isothiocyanate-labeled BSA-LTB NPs into cells was observed using fluorescent imaging. Results showed that BSA-LTB NPs presented a narrow size distribution with an average hydrodynamic diameter of approximately 254±19 nm and a mean zeta potential of approximately -19.95±0.94 mV. In addition, approximately 80.1% of drug was encapsulated in NPs and released in the biphasic pattern. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay showed that BSA-LTB NPs exhibited higher cytotoxic activity than non-targeted NPs (BSA NPs) in SMMC-7721 cells. Fluorescent imaging results proved that, compared with BSA NPs, BSA-LTB NPs could greatly enhance cellular uptake. Hence, the results indicate that BSA-LTB NPs could be a potential nanocarrier to improve targeted delivery of 5-fluorouracil to tumor cells via mediation of LTB. Keywords: heat-labile enterotoxin subunit B, nanoparticle, bovine serum albumin, 5-fluorouracil
format	article
author	Zhao L Su R Cui W Shi Y Liu L Su C
author_facet	Zhao L Su R Cui W Shi Y Liu L Su C
author_sort	Zhao L
title	Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation
title_short	Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation
title_full	Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation
title_fullStr	Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation
title_full_unstemmed	Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation
title_sort	preparation of biocompatible heat-labile enterotoxin subunit b-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit b mediation
publisher	Dove Medical Press
publishDate	2014
url	https://doaj.org/article/9114697ab4b548d284f2f0c7cd208140
work_keys_str_mv	AT zhaol preparationofbiocompatibleheatlabileenterotoxinsubunitbbovineserumalbuminnanoparticlesforimprovingtumortargeteddrugdeliveryviaheatlabileenterotoxinsubunitbmediation AT sur preparationofbiocompatibleheatlabileenterotoxinsubunitbbovineserumalbuminnanoparticlesforimprovingtumortargeteddrugdeliveryviaheatlabileenterotoxinsubunitbmediation AT cuiw preparationofbiocompatibleheatlabileenterotoxinsubunitbbovineserumalbuminnanoparticlesforimprovingtumortargeteddrugdeliveryviaheatlabileenterotoxinsubunitbmediation AT shiy preparationofbiocompatibleheatlabileenterotoxinsubunitbbovineserumalbuminnanoparticlesforimprovingtumortargeteddrugdeliveryviaheatlabileenterotoxinsubunitbmediation AT liul preparationofbiocompatibleheatlabileenterotoxinsubunitbbovineserumalbuminnanoparticlesforimprovingtumortargeteddrugdeliveryviaheatlabileenterotoxinsubunitbmediation AT suc preparationofbiocompatibleheatlabileenterotoxinsubunitbbovineserumalbuminnanoparticlesforimprovingtumortargeteddrugdeliveryviaheatlabileenterotoxinsubunitbmediation
_version_	1718403569922605056

Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation

Ejemplares similares